Factors affecting the determination of threshold doses for allergenic foods: How much is too much? by Taylor, Steve L. et al.
University of Nebraska - Lincoln 
DigitalCommons@University of Nebraska - Lincoln 
Faculty Publications in Food Science and 
Technology Food Science and Technology Department 
July 2002 
Factors affecting the determination of threshold doses for 
allergenic foods: How much is too much? 
Steve L. Taylor 
Lincoln, Nebraska, staylor2@unl.edu 
Susan L. Hefle 
Lincoln, Nebraska 
Carsten Bindslev-Jensen 
Odense, Denmark 
S. Allan Bock 
Boulder, Colorado 
A. Wesley Burks Jr. 
Little Rock, Ark 
See next page for additional authors 
Follow this and additional works at: https://digitalcommons.unl.edu/foodsciefacpub 
 Part of the Food Science Commons 
Taylor, Steve L.; Hefle, Susan L.; Bindslev-Jensen, Carsten; Bock, S. Allan; Burks, A. Wesley Jr.; Christie, 
Lynn; Hill, David J.; Host, Arne; Hourihane, Jonathan O'B.; Lack, Gideon; Metcalfe, Dean D.; Moneret-
Vautrin, Denise Anne; Vadas, Peter A.; Rance, Fabienne; Skrypec, Daniel J.; Trautman, Thomas A.; 
Malmheden Yman, Ingrid; and Zeiger, Robert S., "Factors affecting the determination of threshold doses 
for allergenic foods: How much is too much?" (2002). Faculty Publications in Food Science and 
Technology. 37. 
https://digitalcommons.unl.edu/foodsciefacpub/37 
This Article is brought to you for free and open access by the Food Science and Technology Department at 
DigitalCommons@University of Nebraska - Lincoln. It has been accepted for inclusion in Faculty Publications in Food 
Science and Technology by an authorized administrator of DigitalCommons@University of Nebraska - Lincoln. 
Authors 
Steve L. Taylor, Susan L. Hefle, Carsten Bindslev-Jensen, S. Allan Bock, A. Wesley Burks Jr., Lynn Christie, 
David J. Hill, Arne Host, Jonathan O'B. Hourihane, Gideon Lack, Dean D. Metcalfe, Denise Anne Moneret-
Vautrin, Peter A. Vadas, Fabienne Rance, Daniel J. Skrypec, Thomas A. Trautman, Ingrid Malmheden 
Yman, and Robert S. Zeiger 
This article is available at DigitalCommons@University of Nebraska - Lincoln: https://digitalcommons.unl.edu/
foodsciefacpub/37 
Rostrum 
Factors affecting the determination of 
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Background: Ingestion of small amounts of an offending food 
can elicit adverse reactions in individuals with IgE-mediated 
food allergies. The threshold dose for provocation of such reac- 
tions is often considered to be zero. However, because of vari- 
ous practical limitations in food production and processing, 
foods may occasionally contain trace residues of the offending 
food. Are these very low, residual quantities hazardous to 
allergic consumers? How much of the offending food is too 
much? Very little quantitative information exists to allow any 
risk assessments to be conducted by the food industry. 
Objective: We sought to determine whether the quality and 
quantity of existing clinical data on threshold doses for com- 
monly allergenic foods were sufficient to allow consensus to be 
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reached on establishment of threshold doses for specific foods. 
Methods: In September 1999,12 clinical allergists and other 
interested parties were invited to participate in a roundtable 
conference to share existing data on threshold doses and to 
discuss clinical approaches that would allow the acquisition of 
that information. 
Results: Considerable data were identified in clinical files 
relating to the threshold doses for peanut, cows' milk, and egg; 
limited data were available for other foods, such as fish and 
mustard. 
Conclusions: Because these data were often obtained by means 
of different protocols, the estimation of a threshold dose was 
very difficult. Development of a standardized protocol for clin- 
ical experiments to allow determination of the threshold dose 
is needed. (J Allergy Clin Immunol2002;109:24-30.) 
Key words: Allergy, food, chullmge, threshold dose 
How much is too much? Allergists laow that exposure 
to small quantities of the offending food can elicit 
adverse reactions, sometimes even severe reactions, in 
individuals with IgE-mediated food a l l e rg ie~ .~ .~  For all 
practical purposes, allergists have always assumed that 
the threshold dose for the offending food was zero. When 
advising patients to adhere to specific avoidance diets, 
such advice is probably prudent. 
FOOD INDUSTRY PREDICAMENT 
A zero tolerance for the offending food creates enor- 
mous practical problems for the food industry. From a 
practical economic perspective, the food industry must 
manufacture many different food products within the 
same manufacturing facility. In some facilities several 
hundred different products are manufactured within a sin- 
gle building. In such situations trace residues of a specif- 
ic food could come into contact with another food being 
manufactured in the same facility.L4 Furthermore, the 
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food industry often uses shared equipment to manufacture 
related food products. A few examples include ice cream 
and sorbet, cookies or other baked goods with varying 
formulations, egg-free and egg-containing pastas, and 
chocolate confections with differing ingredients. When 
one product containing a food allergen is manufactured 
on shared equipment just before another product that does 
not contain the same food allergen, the equipment must 
be scrupulously cleaned between manufacturing of the 2 
products. This is necessary to avoid the possibility that 
potentially hazardous residues of an allergenic food will 
enter a product that is not supposed to contain that ingre- 
dient. But how clean is clean enough? 
The chains of distribution of foods and their ingredi- 
ents can be quite complex in today's worldwide food 
industry. Opportunities exist for food products to come 
into contact with allergenic foods or ingredients through- 
out this complex supply chain. As an example, soybeans 
and corn are often harvested on the same Midwestern US 
farms at the same time of the year. Harvesting equip- 
ment, transportation vehicles, and storage facilities are 
often shared. Corn, which is not typically an allergenic 
food, can become contaminated with residual soybeans, 
a more common allergenic food. This contamination can 
be carried through to processed corn products. Are low 
levels of residual soybeans in corn products potentially 
harmful to consumers with soybean allergy? 
These situations illustrate the plight faced by the food 
industry in their efforts to protect the well-being of aller- 
gic consumers. The farm-to-table food production, pro- 
cessing, and distribution chain needs better information on 
the threshold dose for provocation of allergic reactions to 
foods. The proliferation of precautionary labels (eg, "may 
contain peanuts") is an industry response to the existing 
uncertainty. Without information on threshold doses, it is 
difficult for the food industry to conduct risk assessments 
and to focus their quality-control efforts where the benefit 
to the allergic consumer would be the greatest. 
CLINICAL CONSIDERATIONS 
The medical community would also benefit from 
increased information regarding threshold doses. These 
same situations described above create questions for aller- 
gists and their patients with food allergy that cannot be ade- 
quately answered without some knowledge of the threshold 
dose below which reactions are unlikely to occur. 
Evidence is needed on the threshold dose for the 
offending food among sensitive individuals and the level 
of the offending food present in the food product under 
consideration to conduct an assessment of the risk posed 
by trace residues of allergenic foods in other food prod- 
ucts. The threshold dose might best be defined as the 
lowest amount of the offending food that would elicit 
mild, objective symptoms (eg, mild urticaria, erythema, 
and oral angioedema) in the most sensitive individuals. 
The amount of the offending food needed to elicit symp- 
toms is variable, possibly over an order of magnitude or 
more between different individuals with the same type of 
food allergy.5 Many factors contribute to this variability. 
Intraindividual variability probably also occurs as a 
result of potentiating factors, such as exercise, alcohol, 
and acetylsalicylic acid.6 Also, the threshold doses for 
different allergenic foods (eg, peanuts and eggs) are not 
necessarily equal. 
EPISODES ASSOCIATED WITH UNDECLARED 
ALLERGENS IN FOODS 
Presently, very little information exists on the basis of 
which to estimate the threshold dose for specific allergenic 
foods. Anecdotal reports indicate that reactions have 
occurred from such incidental contacts as opening pack- 
ages of the offending food, wiping counters or tables hav- 
ing peanut residues, inhaling vapors from cooking of the 
food, use of shared utensils, and kissing the lips of some- 
one who has eaten the offending food.7 Although such 
anecdotal reports confirm that ingestion of very small 
amounts of allergenic foods may provoke allergic reac- 
tions in some sensitive individuals, they do not provide 
quantitative information on the lowest provol<ing dose. 
More quantitative estimates of the lowest provol<ing 
dose can be derived from actual allergic reactions occur- 
ring in patients from whom careful histories are taken 
regarding the amount of the offending food that was 
ingested. In the case of foods contaminated with trace 
residues of an allergenic food, such histories must be 
coupled with a quantitative analysis of the amount of the 
allergenic food found in the implicated product. Com- 
paratively few such estimates have been made involving 
a rather small number of individuals. This is probably 
because of the lack of simple methods for the analysis of 
the implicated food product for residues of commonly 
allergenic foods. In the investigation of a case involving 
frozen Tofutti containing undeclared mill< residues, the 
ingestion of an amount of tofutti equivalent to 2.5 mL of 
milk elicited a r ea~ t ion .~  In the investigation of a case 
involving hot dogs containing undeclared mill< residues, 
the ingestion of an amount of the hot dogs equivalent to 
0.3 mL of milk elicited reactions in several children.2 In 
a case involving the ingestion of sorbet manufactured on 
shared equipment with ice cream, a child with milk aller- 
gy reacted after eating an unknown amount of sorbet 
containing 0.52% (wtlwt) milk protein.4 In a similar 
episode a child with mill< allergy apparently reacted after 
eating approximately 4 to 6 oz of sorbet containing less 
than 200 pg of whey protein.' Malmheden Yman et a18 
reported a series of incidents related to inadvertent or 
unexpected exposure to allergenic foods that resulted in 
allergic reactions among sensitive individuals. Many of 
these incidents involved exposure to small quantities of 
26 Taylor et al J ALLERGY CLlN IMMUNOL 
JANUARY 2002 
the offending food, including milk in 9 incidents at lev- 
els ranging from 0.04% to 1.1% (wtlwt), egg in 3 inci- 
dents at levels ranging from 0.003% to 0.16% (wt/wt), 
wheat gluten in 2 incidents at levels ranging from 0.3% 
to 1.3% (wtlwt), soy protein in 2 incidents at levels rang- 
ing from 0.5% to 7.0% (wt/wt), and hazelnut in 1 inci- 
dent at a level of 0.2% (wt/wt). Quantitative exposure 
information was available in several of these cases. Fatal 
anaphylaxis occurred in a consumer with milk allergy 
after eating approximately 100 g of a sausage product 
containing 0.06% undeclared casein that equated to 60 
mg of casein.8 An asthmatic reaction occurred in an indi- 
vidual with hazelnut allergy after ingestion of about 3 to 
6 g of a chocolate confection containing 0.2% of unde- 
clared hazelnut that equated to 6 to 12 mg of hazelnut.8 
Although such episodes reveal the hazards posed by 
undeclared residues of allergenic foods contaminating 
other foods, they are not particularly suitable for estab- 
lishing the lowest provoking dose. For example, the cir- 
cumstances of exposure, including the amount and type 
of foods eaten during the episode, can only be deter- 
mined anecdotally. Also, the reliability of the analytic 
results can be questioned because validated, collabora- 
tively studied, standard methods are not yet available. 
CLINICAL APPROACHESTOTHRESHOLD 
DOSE ESTIMATION 
The best estimates of the threshold dose for various 
allergenic foods can be obtained from controlled clinical 
challenge trials. In only a few cases were such trials intend- 
ed specifically to determine the threshold dose.5.9 More fre- 
quently, challenges have been conducted for diagnostic 
purposes rather than for determining the lowest provoking 
dose. However, typical protocols involve starting at doses 
that are one half or less of the amount of the offending food 
estimated by the patient to provoke syrnptoms.'o 
Because low doses of allergenic foods are sometimes 
used in the diagnosis of food allergies, especially in 
patients with histories of serious allergic reactions, the 
possibility exists that data on the threshold doses for 
common allergenic foods might exist in certain allergy 
clinics. Consequently, in September 1999, the Food 
Allergy Research and Resource Program at the Universi- 
ty of Nebraska, with sponsorship from the food industry, 
convened a roundtable conference entitled "Threshold 
Doses for Allergenic Foods: How Much Is Too Much?" 
RESULTS OFTHE ROUNDTABLE 
Several clinical groups did possess potentially useful 
information relating to the threshold doses for commonly 
allergenic foods derived from the results of past double- 
blind, placebo-controlled, food challenges (DBPCFCs) 
used for diagnostic purposes. The most useful data were 
available on peanuts, eggs, and cows' milk and will be 
reported here. Some data were also available on fish and 
mustard seed. Data were also available for soybeans, 
wheat, sesame seed, tree nuts, and crustaceans, but the 
number of vatients tested was too few, and in some cases, 
the nature of the challenge materials was not precisely 
known (eg, the variety of tree nuts, the form of soybean, 
and the method of processing or species of crustacean). 
Table I contains the results of the accumulated data on 
the lowest provoking doses in DBPCFCs for the various 
investigators involved in the roundtable conference for 
peanuts, eggs, and cows' milk. For peanut, results were 
shared on DBPCFCs (and some single-blind, placebo- 
controlled food challenges [SBPCFCs] and open chal- 
lenges) of 306 patients. The lowest provoking dose was 1 
mg of peanut, which was seen with 4 patients; all of these 
patients were from the clinic of Dr Fabienne Rance in 
France. The range of lowest provoking doses for these 
patients was 1 mg to 5 g. For eggs, results were shared on 
DBPCFCs (and some SBPCFCs and open challenges) of 
281 patients. The lowest provoking dose was 1 mg of liq- 
uid whole egg, which was seen with 2 patients, both from 
the clinic of Dr Rance in France. The range of lowest 
provoking doses for these patients was 1 mg to 5 g. For 
cows' milk, the results are much more difficult to inter- 
pret because several different forms of cows' milk were 
used in the challenges: liquid cows' milk, nonfat dry 
milk, and infant formula. For cows' milk, results were 
shared on DBPCFCs (and a few SBPCFCs and open 
challenges) of 299 patients. The lowest provoking dose 
was 0.02 mL of milk, which was seen in 21 patients; all 
of these patients were from the clinic of Dr David Hill 
from Australia. The range of lowest provoking doses for 
these patients was 0.02 m~ to greater than 100 mL. For 
fish, the lowest provoking dose was 5 mg of either cod or 
herring, as determined from the results of DBPCFCs 
(and some SBPCFCs) on 32 patients. However, the 
species of fish used in these challenges were variable, 
and this appeared to affect the results, as noted from 
comparative information obtained on 14 patients for 4 
different species by Dr Carsten Bindslev-Jensen in Den- 
mark. Fifteen individuals with mustard allergy have been 
evaluated by means of DBPCFCs in France, and the most 
sensitive individual reacted to 1 mg of ground mustard 
seed. To apply this information in the context of a typical 
serving of food containing undeclared residues of an 
allergenic food, 1 mg of an allergenic food in a typical 
50-g serving would be equivalent to 20 mg of allergenic 
food per kilogram of the ingested food product (20 ppm). 
DISCUSSION 
Clearly, sufficient results are available to conclude that 
the threshold doses for commonly allergenic foods are 
finite, measurable, and above zero. However, attempting 
to reach consensus on the threshold doses for peanut, 
egg, cows' milk, fish, and mustard on the basis of the 
existing data would probably be premature for a number 
of reasons. The number of patients who have been sub- 
jected to DBPCFCs with low doses of the offending food 
is probably sufficient to estimate the threshold dose at 
least for peanut, egg, and cows' milk. However, the 
nature of the data suggests that it may be premature to 
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TABLE I. Lowest provoking dose for commonly allergenic foods 
Nature of Lowest provoking dose 
Physician No. of challenges 
or group patients (DB or SB) Amount of food Amount of protein Form 
Peanut Hourihane 
National Jewish 
Bindslev-Jensen and Mortzi 
Bock 
Burks and Christie 
Lack 
Hill 
Rance 
Moneret-Vautrin #1 
Moneret-Vautrin #2 
Egg Moneret-Vautrin #1 
Moneret-Vautrin #2 
Bock 
Bindslev-Jensen and Norgaard 
Burks and Christie 
Hill 
Rance 
Lack 
Lack 
Milk Bindslev-Jensen and ~ o r ~ a a r d l l  
Hill 
Bock 
Burks and Christie 
Rance 
Lack 
Moneret-Vautrin #1 
Zeiger 
Host 
Fish Rance 
Moneret-Vautrin #1 
Bindslev-Jensen and Hansenii 
Bindslev-Jensen and Hansenii 
Bindslev-Jensen and Hansenii 
Bindslev-Jensen and Hansenii 
Bock 
Mustard Rance 
14 DB 
3 DB 
5 DB 
69 DB 
10 DB 
6 SB 
100 Open 
74 DB 
28 DB or SB 
9 DB or SB 
19 DB 
8 DB or SB 
91 DB 
100 Open 
3 8 DB 
13 SB 
5 SB 
3 DB 
100 Open 
66 DB 
21 DB 
3 1 DB 
6 SB 
6 DB or SB 
56 DB 
15.Ahh DB 
15.1** DB 
6 DB 
4 DB or SB 
14 DB 
14 DB 
4.3 mg 
10 mg 
160 mg 
50 mg 
400 mg 
500 mg 
1 drop of PB 
I mg 
5 mg (SB), 10 mg (DB) 
265 mg 
2 mg 
265 mg 
20 mg 
100 mg 
200 mg 
5000 mg 
0.02 mL 
2 mL 
400 mg 
0.5 mL 
5 mL 
I mL (DB), 5 mL (SB) 
0.1 mL 
5 mL 
5 mL 
16 mg 
15 mg (SB), 65 mg (DB) 
5 mg 
500 mg 
2 mg 
2.5 mg 
40 mg 
1.25 mg 
I00 mg 
125 mg 
6 mg 
0.25 mg 
1.25 mg, 2.5 mg 
66 mg 
0.2 mg 
26.5 mg 
10 mg 
20 mg 
180 mg 
0.6 mg 
67 mg 
140 mg 
15 mg 
150 mg 
30 mg, 150 mg 
1.5 mg 
75 mg 
75 mg 
Unknown?? 
Unknown 
Unknown 
Unknown 
Unknown 
Unknown 
Unknown 
0.3 mg 
PF? 
Ground peanut 
Ground peanut 
Ground peanut 
PB 
Ground peanut 
PB 
Ground peanut 
Ground peanut 
Ground peanut 
EW§ 
EW§ 
Dried EW or 
whole egg 
Whole eggq 
(raw) 
Dried whole 
egg 
EW (raw) 
Whole egg 
(raw) 
EW (cook) 
EW (raw) 
Milk 
Milk 
NFDM 
NFDM 
Milk 
Milk 
Milk 
Formula# 
Formula# 
Formula# 
Minced fish 
Minced fish 
Minced cod 
Minced 
mackerel 
Minced herring 
Minced plaice 
Minced fish 
Ground mustard 
seed 
DB, Double-blind; SB,  s~ngle-blind; PF, Peanut tlour; PB, peanut butter; EW, egg wh~te;  NFDM, nonfat dry mllk. 
+Peanut tlour is assumed to contain 50% protein unless the value is specifically known. 
?Work conducted also with Charlotte Mortz, PhD. 
$Li uid egg white has an average protein content of 10%; dried egg whlte has an average protein content of 90%. 
~ 0 %  conducted also with Astrid Norgaard, PhD. 
YlWhole egg has an average of 13% protein on a liquid basis and 50% protein on a dry basis. 
#Cows' milk formula is estimated to conrain 15 g of milk protein per liter. 
""Cows' milk allergy (A) or cows' milk intolerance (I). 
++The protein content of the fish was not measured and may have been variable on the basis of the type of fish used 
ZZWork conducted also with Tine Hansen, PhD. 
attempt such an estimate. Because the experiments were ing consensus on the basis of the current data set. Cer- 
usually designed for diagnostic purposes rather than for tainly, a variety of different protocols were used in the 
determination of the threshold dose, several experimental various clinics where the data were generated. Thus com- 
design elements may contribute to the difficulty in reach- mingling of the data may not be entirely appropriate. 
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TABLE II. Typical amounts o f  protein in  challenge vehicles 
Food-challenge material 
Typical amount of protein contained* 
m L Fluid oz FI 
Whole m i k  30-36 g 30-36 mg 
Infant formula (milk protein) 15 g 15 mg 
NFDM 
Egg white, liquid 10 g 10 mg 
Whole egg, liquid 13 g 13 mg 
Egg white, dried 
Whole egg, dried 
Peanut butter 
Peanut flour, defatted 
NFDM, Nonfat dly milk. 
*Units of measure, such as drops or teaqpoonr (for dried or parte materials), can be dificult to quantify 
The major reason for not estimating a threshold dose 
on the basis of the available data is that the no-observed- 
adverse-effect level (NOAEL) was not established for the 
vast majority of the patients involved in these trials. In 
risk assessments used by the World Health Organization, 
the Food and Agriculture Organization of the United 
Nations, and various worldwide regulatory agencies to 
establish acceptable daily intakes (virtually safe doses) 
for food additives, the NOAEL is first established on the 
basis of research with experimental animals or observa- 
tions on human subjects." Uncertainty factors are then 
applied, on the basis of such factors as the need to extrap- 
olate from experimental animals to human subjects, to 
estimate the acceptable daily intake.12 Regulatory toxi- 
cologists often apply an uncertainty factor of 10 when 
attempting to extrapolate data from experimental animals 
to human subjects. Another factor of 10 is often applied 
to account for possible human-to-human variability. 
Thus the NOAEL generated from a toxicologic study in 
rats or mice is typically divided by 100 to estimate a safe 
dose for human subjects.l' In attempting to estimate a 
threshold dose for allergic individuals from the available 
clinical data, a key issue would be the magnitude of the 
uncertainty factor to use in the risk assessment. A factor 
of 10 would generally be considered appropriate in most 
situations in which experimental data are available on 
human subjects, but the suitability of this uncertainty fac- 
tor for application to the determination of threshold 
doses for allergenic foods requires extensive discussion. 
In the data presented at this roundtable conference, the 
lowest provoking dose for each individual patient was 
known. For risk-assessment purposes, this dose would be 
the lowest-observed-adverse-effect level (LOAEL). 
Because the DBPCFCs were being performed for diag- 
nostic purposes, only the LOAEL was recorded. For the 
purposes of estimating a threshold dose, it would be 
preferable to have information on the NOAEL. The high- 
est dose in the DBPCFCs that did not elicit an adverse 
reaction should be known to determine the NOAEL. 
However, that information was not generally available 
because the most sensitive patients involved in these chal- 
lenge trials reacted to the first and lowest dose used. This 
dose is thus the LOAEL, and uncertainty exists about how 
much less of the offending food would be required to 
reach the NOAEL. Although the LOAEL could be used to 
estimate the threshold dose, that would introduce an addi- 
tional uncertainty factor of indeterminate magnitude. 
Because an uncertainty factor would need to be applied to 
estimate the NOAEL from the LOAEL and because no 
consensus has been reached on the size of that uncertain- 
ty factor, no attempt was made at this time to estimate a 
NOAEL for peanut, egg, or milk. 
Other factors also argue against establishment of a 
threshold dose at this time. One question involves 
whether the patients selected for DBPCFCs are represen- 
tative of the entire population of individuals with aller- 
gies to that specific food. Most physicians acknowledge 
excluding some of the most seriously affected patients 
(ie, those with histories of anaphylactic shock) from 
challenge trials. It could be argued that these patients 
may be among the very most sensitive. Therefore if using 
data on the basis of an incomplete set of the relevant 
patients, some adjustments might need to be made with 
uncertainty factors. In the data presented here, some 
physicians excluded severely affected patients, whereas 
others did not. In consideration of the existing data on 
threshold doses for allergenic foods, the critical debate 
might center around whether the usual 10-fold uncertain- 
ty factor would be suficient to account for the most sen- 
sitive individuals in the population, who may not have 
been included in the clinical experiments. Would indi- 
viduals exist who were more than 10 times as sensitive as 
the most sensitive individual in the tested group? 
The age and body weight of the patients may also be a 
consideration. The lowest provoking doses expressed in 
Table I are presented as milligrams of protein or food. 
Some of the challenges were conducted on infants and 
young children, whereas others were conducted on 
adults. Should provoking doses be expressed on a weight 
basis (eg, milligram per kilogram) of body weight? 
The nature of the challenge material is another factor 
creating some uncertainty. The standardization of chal- 
lenge materials would certainly ease the comparative 
interpretation of the results. For peanut, most clinicians 
used ground peanuts as their challenge material and 
expressed their results as milligrams of peanut. However, 
J ALLERGY CLlN IMMUNOL 
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in one case Deanut butter was used. In another cases 
peanut flour was used. In such cases assumptions must 
be made in expressing the challenge doses in milligrams 
of peanut or peanut protein. For eggs, most of the inves- 
tigators used egg white as the challenge material, 
although some used whole egg. One investigator used 
both raw and cooked egg white. In Table I the results 
were converted to milligrams of egg protein to obtain a 
more consistent basis for comparison. With cows' milk, 
the situation is even more confusing. Liquid milk, nonfat 
dry milk, and infant formula are used as challenge mate- 
rials. In Table I the data were converted to milligrams of 
- 
milk protein, but the conversion required some important 
assumptions regarding appropriate conversion factors. 
Table I1 provides a summary of the differing amounts of 
protein found in various forms of cows' milk, egg, and 
peanut. These differences highlight the interpretive prob- 
lems associated with the use by various clinicians of dif- 
ferent forms of the specific foods in the challenge. Stan- 
dardization of this aspect would be helpful in obtaining 
easily comparable data from different clinics. 
The specific allergen content of the challenge materi- 
als may also affect the estimation of the threshold dose. 
Peanut, cows' milk, and egg contain multiple aller- 
gens,14-16 and individual patients respond to different 
allergens.17.18 If the content of the specific allergens 
varies from one challenge material to another. that could 
- 
affect the likelihood that certain patients would react at 
specific low doses and the estimation of the threshold 
dose. For example, the proportion of the major egg aller- 
gens Gal d 1 and Gal d 2 as a function of total protein 
would be higher in egg white than in whole egg. Howev- 
er, this consideration lilcely has little effect on the data for 
cows' millc and peanut because the proportion of specif- 
ic allergens as a function of total protein would not 
change as a consequence of defatting or other processes. 
Also, in the case of peanut, little difference appears to 
occur in the specific allergen content as a function of 
variety or agronomic conditions.lg 
Other features of the challenge trials were also vari- 
able, which introduces additional uncertainty. As already 
aclcnowledged, a few challenges, usually on the very 
youngest patients, were done single-blind or open rather 
than double-blind. Labial challenges are also occasional- 
ly used, although no such data are actually reported in 
Table I. In addition to the nature of the challenge mate- 
rial, as noted above, the nature of the challenge vehicle 
also varies, although this hopefully has limited effect on 
the results. The time interval between administration of 
the doses in a DBPCFC also varies. However, this factor 
likely did not have much effect on the estimation of the 
lowest provoking dose because the most sensitive 
patients reacted to the first dose administered. Clearly, 
the determination of the NOAEL and the estimation of 
the threshold doses would be much easier if the 
DBPCFCs were standardized with respect to all of the 
important factors. 
Once a NOAEL is obtained (and it is possible to esti- 
mate a NOAEL from a LOAEL by applying some uncer- 
tainty factor), then the threshold dose could be estimated 
by the application of additional uncertainty factors. The 
primary source of remaining uncertainty would be with 
regard to human-to-human variability. Although data 
were obtained from DBPCFCs on more than 250 subjects 
with peanut, egg, and cows' milk, the range of lowest pro- 
voking doses was widely variable from one individual to 
the next. The range was several orders of magnitude for 
all 3 foods. But the most sensitive individual may not 
have been included in any of these trials. Therefore some 
uncertainty factor would need to be applied to the avail- 
able data. However, because the risk assessment process 
was quite new to most of those attending this roundtable 
conference, no consensus was reached on the magnitude 
of the uncertainty factor that would be applied. 
Some uncertainty will likely always remain regarding 
whether the threshold dose has been determined for the 
most sensitive individuals. Clinicians will never be com- 
pletely certain that the most sensitive individual has been 
identified and tested. However, an analogy can likely be 
drawn to the infant formula industry, in which hypoaller- 
genic infant formula based upon extensively hydrolyzed 
casein is safe for the vast majority of infants with milk 
allergy. Yet hypoallergenic infant formula is known to 
elicit adverse reactions in a very small minority of such 
infants. This analogy illustrates the difficulty in develop- 
ing threshold doses, even with the application of uncer- 
tainty factors that will protect all allergic consumers. 
Instead, the goal should be to identify threshold doses 
that protect the vast majority of allergic consumers. Fur- 
thermore, the use of an uncertainty factor, as described 
earlier, may correct these concerns. 
In summary, the threshold doses for peanut, egg, and 
cows' milk appear to be in the low milligram range or 
higher for most individuals with allergies to those partic- 
ular foods. Thus these individuals can (and probably do) 
ingest foods, on occasion, containing lower amounts of 
their offending food without any untoward reactions. We 
recommend that international efforts be undertalcen to 
establish threshold doses for commonly allergenic foods 
using standardized clinical challenge protocols and using 
as wide a range of affected patients as possible. 
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